Speakers
speakers
Thibaud Damy
Henri Mondor University Hospital
Paris, France
Pr Damy’s field of interest are Heart failure and amyloidosis, through to their diagnosis and treatment. His particular current interests include early cardiac diagnostic markers, from biology to imaging. He is a co-author of 150 articles (>60 on amyloidosis). Professor Damy created the “Mondor Amyloidosis Network”, which involves all the clinical facilities for the diagnosis and and treatment of amyloidosis, in addition to a clinical research team. It rapidly became an important multidisciplinary network involving more than 40 healthcare professional. Since 2010, more than 2,800 patients have been referred to the centre for suspicion of cardiac amyloidosis . Professor Damy and his team created a wide educational programme to improve the knowledge and quality of life of the patients: Amylo Patient Education Program (Amylo-PEP). In 2017, the Mondor Amyloidosis Network was appointed Referral Center for Cardiac Amyloidosis in the Cardiogen FrenNetwork.
Donato Amodio
Ospedale Pediatrico Bambino Gesù
Rome, Italy
Stephen Greene
Duke University
Durham NC, United States
Stephan Greene a cardiologist with a clinical and research interest in heart failure. He take care of patients with various types of heart failure, including patients who are best treated with medications and patients who receive advanced therapies like heart transplantation and mechanical assist devices. He became a heart failure cardiologist to help patients manage their heart conditions and best achieve their goals for their health. Hr is strongly committed to helping patients thoroughly understand their medical conditions and helping them make informed medical decisions aligned with their preferences.
His research interests are focused on strategies and therapies to improve outcomes and quality of life for patients with heart failure. This involves research through clinical trials and through examining data from real-world clinical practice.
Anne-Li Lind
Olink Proteomics
Uppsala - Sweden
Anne-Li Lind is a doctor of medical science specialized in chronic pain research with more than 10 years of experience in medical molecular neuroscience and of human biofluid proteomic methods. She is excited about making contributions to public health and sustainability. She loves a challenge and particularly enjoy working with a focused, creative, multi-professional team to meet goals and requirements.
She is delighted to conduct scientific investigations, collect and analyze data, read, interpret and communicate medical science in collaboration with study participants, public, clinicians, scientists, management, and students.
Colleagues describe her as energetic, creative, driven, responsible and helpful. In a project She was able to turn complexity into concrete to-dos and get them done. She also enjoys vision and strategy work.
Maja Cikes
University of Zagreb
Zagreb - Croatia
Mattias Johannsson
IARC,
Lyon - France
Carmen
Lefaucheur
AP-HP,
Nancy/Monaco - France
Muthiah Vaduganathan
Brigham and Women's Hospital,
Bosten Ma - United States
Soumeya Bekri
CHU Rouen,
Rouen - France
Jon Cunningham
Brigham and Women's Hospital
Bosten Ma - United States
Harriette Van Spall
McMaster University,
Hamilton - Canada
LinaYa'Qoub
University of California - San Francisco
San Francisco CA- United States
Karen Sliwa
University of Cape Town ,
Cape Town- South Africa
Professor Karen Sliwa is a senior cardiologist working at the Division of Cardiology, Department of Medicine, Groote Schuur Hospital, University of Cape Town and at UCT Private Academic Hospital. Her special areas of expertise are heart failure, structural heart diseases such as cardiomyopathy and cardiac disease in pregnancy. She is the Director of the Cape Heart Institute, Faculty of Health Sciences, University of Cape Town- a translational cardiovascular research Institute with 7 working groups. Prof. Sliwa is widely recognised as a world expert in cardiovascular diseases (CVDs), with a special interest in reducing mortality in women with cardiac disease in maternity. She has contributed to better understanding on the pathophysiology, treatment options and awareness of peripartum cardiomyopathy (PPCM), a global disease particularly prevalent in African populations. She led and still leads several inter-Africa and global research projects, which have had a major impact for creating knowledge about CVDs common in Africa and other Middle-to-Lower income regions, leading to changes in policy. Her considerable experience in setting up simple, cost-effective registries and web-based data entry platforms have had a major impact on planning several innovative research projects and has facilitated the training of physicians from several African countries, including Mozambique, Nigeria, Cameroon, Uganda and Tanzania. Her translational research from bench-bed-to-population studies have led to a much better understanding of CVDs such as rheumatic heart disease and heart failure due to various causes and subsequently to improved patient care. She holds numerous awards such as the German Cardiac Society Paul Morawitz Award for Exceptional Cardiovascular Research ( 2013), a Honorary Doctorate University Diderot-Sorbonne, Paris, France (2017), European Cardiac Society Geoffrey Rose Award for Population Sciences ( 2019) and the South African Medical Research Council Gold award ( 2021). She has authored more than 350 publications, trained more then 30 post graduate students. Her work is highly cited ( H- index 88). Professor Sliwa leads several high-profile special interest groups including a dedicated EORP Working Group on PPCM of the Heart Failure Association of European Society of Cardiology and the World Heart Federation Expert Group on Neglected Cardiovascular Diseases. Over her distinguished career she has served in many notable roles, including chair of the South African Heart Failure Association ( HeFSSA), President of the South African Heart Association (2014-2016), President of the World Heart Federation (2019-2020) and currently Vice president Southern Region Pan African Society of Cardiology ( 2016-2021).
Nancy Ip
Hong Kong University of Science and Technology,
Hong Kong- Hong Kong
Mina Hur
Konkuk University,
Seoul - South Korea
Ben Lacey
UK Biobank, University of Oxford,
Oxford- United Kingdom
Reinder Broekstra
University of Groningen,
Groningen- Netherlands
Reinder Broekstra conducts research into ethical legal and (psycho)social issues in genetics and genomics. His research interests focus on the implications of innovations, particularly with application of information technology. For example, the implications of consent, communication of findings, and other criteria for data repository in scientific research.
His research during his PhD investigated factors affecting willingness to contribute (personal data) to large-scale, centralized data repositories for scientific (biomedical) research, specifically biobanks.
Amongst other projects during his brief non-academic research career, he investigated the implications of introducing a mobile app for banking to the clients of a renowned bank in the Netherlands.
François Dépret
University of Toronto,
Toronto - Canada
Dr Sabri Soussi completed his specialty training in Anesthesia and Critical Care in 2010 in France and had as of 2011 a clinical associate and then attending physician positions in the Medical Surgical and Cardiovascular ICUs of La Pitié-Salpétrière and Lariboisière-St Louis University Hospitals (Paris, France).
In 2018, he obtained a master’s degree in “Clinical Research and Epidemiology” (Sorbonne University, Paris, France). He thereafter started in 2019 a PhD program “Genes, Omics, Bioinformatics and Systems biology” in the University of Paris.
Dr SOUSSI published 32 peer reviewed articles in the last 5 years mainly in the field of shock states monitoring, management and novel biomarkers assessment (e.g., septic, cardiogenic, related to burn injury), in specialty-leading and high-impact medical journals (e.g., Anesthesiology Intensive Care Medicine). He set up a research collaborative network between his inner research group in Saint Louis and Lariboisière Hospitals, Paris, France and the academic group at St Michael’s Hospital, University of Toronto (Dr Claudia DOS SANTOS, Dr Laurent BROCHARD and Dr John MARSHALL).
Jasper Tromp
National University of Singapore,
Singapore - Singapore
Jasper Tromp is a medical doctor (MD) who completed his PhD in Medicine (Cum Laude/Highest distinction) with a strong interest in global health and big data analytics. He is interested in the intersection between biomarkers and heart failure. What can biomarkers tell us about the underlying pathophysiology of heart failure and how can biomarkers be used in clinical practice are central questions to my research.
He is currently a post-doctoral fellow at the National Heart Centre Singapore, Duke-NUS medical school and co-director of the "Cardiovascular Clinical Trial Data Management Centre" at the National Heart Centre. He manages and spearheads several international collaborations with academia and industry which have led to publications in top tier journals including Journal of the American College of Cardiology, Circulation, European Heart Journal and Lancet Global Health.
Andrea Baragetti
University of Milan,
Milan- Italy
Melissa Amrein
University of Basel,
Basel- Switzerland
Melissa Amrein is a PhD candidate at the University Hospital of Basel doing cardiovascular research, whereby her projects deals with analysing biomarkers for the diagnosis and prognosis of functional relevant coronary artery disease.